Back
SpringWorks Therapeutics Vs. Regencell Bioscience Holdings Industry Stock Comparison
Sell
37
SWTX
SpringWorks Therapeutics
Last Price:
$49.89
Seasonality Move:
8.06%
Sell
50
RGC
Regencell Bioscience Holdings
Last Price:
$57.52
Seasonality Move:
5.37%
Sell
37
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy, Sell or Hold?
-
The current SpringWorks Therapeutics [SWTX] share price is $49.89. The Score for SWTX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
SWTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Regencell Bioscience Holdings (RGC)
is a Sell
Is Regencell Bioscience Holdings a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings [RGC] share price is $58.63. The Score for RGC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
RGC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SWTX Stock Price Chart
What is SpringWorks Therapeutics's stock price today?
-
The SpringWorks Therapeutics share price today is $49.89The current trend is moderately bearish and SWTX is experiencing slight selling pressure.
RGC Stock Price Chart
What is Regencell Bioscience Holdings's stock price today?
-
The Regencell Bioscience Holdings share price today is $58.63Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGC is experiencing slight buying pressure.
SWTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.61 | Buy |
| Relative Strength Index (14 RSI): | 49.34 | Sell |
| Chaikin Money Flow: | -951970 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.92 - 56.82) | Sell |
| Bollinger Bands (100): | (32.82 - 49.42) | Buy |
RGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.59 | Buy |
| Relative Strength Index (14 RSI): | 95.36 | Buy |
| Chaikin Money Flow: | 167065 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (-2.84 - 25.82) | Buy |
| Bollinger Bands (100): | (-0.8 - 14.58) | Buy |
SWTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.28 | Sell |
| 20-day SMA: | 52.34 | Sell |
| 50-day SMA: | 46.03 | Buy |
| 200-day SMA: | 38.9 | Buy |
| 8-day EMA: | 50.48 | Sell |
| 20-day EMA: | 50.66 | Sell |
| 50-day EMA: | 47.38 | Buy |
| 200-day EMA: | 40.82 | Buy |
RGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.93 | Buy |
| 20-day SMA: | 13.41 | Buy |
| 50-day SMA: | 7.93 | Buy |
| 200-day SMA: | 6.53 | Buy |
| 8-day EMA: | 31.97 | Buy |
| 20-day EMA: | 18.83 | Buy |
| 50-day EMA: | 11.05 | Buy |
| 200-day EMA: | 7.63 | Buy |
SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $2.06 per share.
Regencell Bioscience Holdings Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SpringWorks Therapeutics Technical Analysis
| Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regencell Bioscience Holdings Technical Analysis
| Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||